Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (25 ops.)
Latest filing published 05 Oct 2026 for Royalty Pharma plc, €210k.
Filing timeline
BuySaleMarshall Urist
Insider track record
Disclosed buys
0
Disclosed sells
25
Signal history
Marshall Urist: trading record in brief
This profile gathers the share dealings of Marshall Urist in Royalty Pharma plc, where the filings describe the role as senior executive. The record holds 34 filings, for trades running from 7 May 2021 to 5 October 2026.
No open-market purchase appears, only 25 sales worth €14.7M. Besides market trades, the filings include 5 share grants. 2026 to date brings no purchases and 8 sales.
The record was last updated on 5 October 2026 with an open-market sale (€210k) in Royalty Pharma plc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Marshall Urist
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
4,126 shares@ US$57.10Class A Ordinary SharesSEC:0001838139-26-000028:0
4,126 shares@ US$57.88Class A Ordinary SharesSEC:0001838139-26-000026:0
8,252 shares0Class A Ordinary SharesSEC:0001838139-26-000024:0
13,684 shares@ US$53.06470.0020% mcap5.0% of flowClass A Ordinary SharesSEC:0001838139-26-000016:0
19,970 shares0Class A Ordinary SharesSEC:0001838139-26-000012:0
20,000 shares@ US$41.09055.5% of flowClass A Ordinary SharesSEC:0001838139-26-000010:0
20,000 shares@ US$40.25555.5% of flowClass A Ordinary SharesSEC:0001838139-26-000008:0
20,000 shares@ US$39.51735.5% of flowClass A Ordinary SharesSEC:0001838139-26-000006:0
20,000 shares@ US$40.78175.6% of flowClass A Ordinary SharesSEC:0001838139-26-000004:0
20,000 shares@ US$38.48255.3% of flowClass A Ordinary SharesSEC:0001838139-26-000002:0
20,000 shares@ US$39.3195.3% of flowClass A Ordinary SharesSEC:0001838139-25-000014:0
20,000 shares@ US$38.37915.2% of flowClass A Ordinary SharesSEC:0001838139-25-000012:0
20,000 shares@ US$38.3215.2% of flowClass A Ordinary SharesSEC:0001838139-25-000010:0
23,334 shares@ US$39.15286.3% of flowClass A Ordinary SharesSEC:0001838139-25-000008:0
23,333 shares@ US$39.92776.4% of flowClass A Ordinary SharesSEC:0001838139-25-000006:0
4,626 shares0Class A Ordinary SharesSEC:0001838139-25-000004:0
2,772 shares0Class A Ordinary SharesSEC:0001802768-25-000101:0
36,484 shares0Class A Ordinary SharesSEC:0001802768-25-000031:0
23,333 shares@ US$37.29656.5% of flowClass A Ordinary SharesSEC:0001209191-23-012883:0
70,000 shares0Class A Ordinary SharesSEC:0001209191-23-010715:0
3,600 shares@ US$43.05141.2% of flowClass A Ordinary SharesSEC:0001209191-22-043282:0
23,333 shares@ US$43.18750.0031% mcap7.7% of flowClass A Ordinary SharesSEC:0001209191-22-039294:0
23,333 shares@ US$39.85077.1% of flowClass A Ordinary SharesSEC:0000899243-22-018222:0
70,000 shares0Class A Ordinary SharesSEC:0000899243-22-017656:0
16,566 shares@ US$45.13234.9% of flowClass A Ordinary SharesSEC:0000950103-21-008573:0
25 of 28 declarations
